Advertisement

Topics

Global Implantable Drug Delivery Devices Market by Products, Technologies, Applications and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.

22:00 EST 10 Mar 2017 | PR.com

Maryland Heights, MO, March 11, 2017 --(PR.com)-- The global implantable drug delivery devices market is estimated to reach USD 22.5 Billion in 2020, growing at a CAGR of 6.0% from 2016 to 2020, due to higher demand for minimally invasive technologies worldwide.

Browse Implantable Drug Delivery Devices Market by Device Types (Bio-Absorbable Stents, Brachytherapy Seeds, Contraceptive Devices, Coronary Drug Eluting Stents, Drug Infusion Pumps, and Intraocular Devices), Technologies (Biodegradable and Non-Biodegradable), and Applications (Contraception, Cardiovascular, Oncology, Ophthalmology, Diabetes, Chronic Pain) 2016-2020 report at https://www.ihealthcareanalyst.com/report/implantable-drug-delivery-devices-market/

Implantable drug delivery devices serve a variety of functions, from vascular stents that preserve blood flow to electro stimulation devices that regulate heart rhythm or block spurious signals in the brain to orthopedic devices that mechanically reinforce the spine or restore range of motion of hips and knees. Implantable devices allow site specific drug administration and allow for sustained release of a therapeutic agents, while the key material considerations include biocompatibility, stability and durability. Higher prevalence of prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, unwanted pregnancies and rapidly aging global population are the driving the global implantable drug delivery devices market.

The global implantable drug delivery devices market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on device type (bio-absorbable stents, brachytherapy seeds, contraceptive devices, coronary drug eluting stents, drug infusion pumps, and intraocular devices), their underlying technologies (biodegradable and non-biodegradable), its applications (contraception, cardiovascular, oncology, ophthalmology, diabetes, chronic pain, etc.), and also forecasts growth trends (CAGR% - 2016 to 2020). The global implantable drug delivery devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global implantable drug delivery devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global implantable drug delivery devices market and included in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/implantable-drug-delivery-devices-market/

About Us

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com

Contact Information:
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
Contact via Email
https://www.ihealthcareanalyst.com/

Read the full story here: http://www.pr.com/press-release/708499

Press Release Distributed by PR.com

Original Article: Global Implantable Drug Delivery Devices Market by Products, Technologies, Applications and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.

NEXT ARTICLE

More From BioPortfolio on "Global Implantable Drug Delivery Devices Market by Products, Technologies, Applications and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...